Sign inJoin
Company / Finance

Elevance Health, Inc.

ELV · NYSE

Elevance reported 2025 revenue of $199.1 billion and first-quarter 2026 revenue of $50.2 billion. The thesis depends on medical-cost control, Medicaid and Medicare trends, commercial pricing, regulation, cash flow and capital allocation.

FollowAdd to WatchlistAsk Question
NYSEELVCoverage BootstrapElevance Health, Inc.
Latest ReportMay 19, 2026Elevance Health: managed-care scale meets the medical-cost testView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Company filters1 company reports
Latest Thesis

Elevance Health: managed-care scale meets the medical-cost test

Elevance reported 2025 revenue of $199.1 billion and first-quarter 2026 revenue of $50.2 billion. The thesis depends on medical-cost control, Medicaid and Medicare trends, commercial pricing, regulation, cash flow and capital allocation.

May 19, 2026Research reportSlides available
Read reportOpen slidesDiscussion (0)
Elevance Health, Inc.Health: managed-care scale meets the medical-cost testMay 19, 2026
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue

Recent Reports

Compact report index for this company.

View all 1 reports ->
ReportTypeUpdatedReadActions
Elevance Health: managed-care scale meets the medical-cost testElevance reported 2025 revenue of $199.1 billion and first-quarter 2026 revenue of $50.2 billion. The thesis depends on medical-cost control, Medicaid and Medicare trends, commercial pricing, regulation, cash flow and capital allocation.NYSEMay 19, 2026Research reportReadSlides